We’re excited to share that we are establishing a collaboration with Stanford GMP Facility: Laboratory for Cell and Gene Medicine(LCGM) to deploy our robotic systems for cell therapy manufacturing!

Combining LCGM’s unmatched process development expertise with our robotic technology enables cell therapy organizations to run side-by-side comparisons of their current manual processes with the corresponding automated processes. We can’t wait for cell therapy leaders to see what’s possible with automation as we take another step forward to reducing barriers to patient access to cell therapies.